Janssen Heralds NICE Ruling on Hepatitis C Drug Olysio For Patients With Genotype 1, Calls For Further Approval For Genotype 4
Hepatitis C, News
The National Institute of Health and Care Excellence (NICE) recently released the Appraisal Consultation Document (ACD) for the use of Olysio® (simeprevir), developed jointly by Janssen R&D Ireland and Medivir ... Read more